FI872393A - Tumoer nekrosfaktorformulation. - Google Patents
Tumoer nekrosfaktorformulation. Download PDFInfo
- Publication number
- FI872393A FI872393A FI872393A FI872393A FI872393A FI 872393 A FI872393 A FI 872393A FI 872393 A FI872393 A FI 872393A FI 872393 A FI872393 A FI 872393A FI 872393 A FI872393 A FI 872393A
- Authority
- FI
- Finland
- Prior art keywords
- tumoer
- necrofactorformulation
- unsubstituted
- polyethylene glycol
- tnf
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86876686A | 1986-05-29 | 1986-05-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI872393A0 FI872393A0 (fi) | 1987-05-28 |
FI872393A true FI872393A (fi) | 1987-11-30 |
Family
ID=25352278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI872393A FI872393A (fi) | 1986-05-29 | 1987-05-28 | Tumoer nekrosfaktorformulation. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0247860B1 (fi) |
JP (1) | JPS62289522A (fi) |
AT (1) | ATE77959T1 (fi) |
AU (1) | AU595321B2 (fi) |
CA (1) | CA1283046C (fi) |
DE (1) | DE3780218T2 (fi) |
DK (1) | DK277187A (fi) |
FI (1) | FI872393A (fi) |
NO (1) | NO872227L (fi) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5091176A (en) * | 1988-11-02 | 1992-02-25 | W. R. Grace & Co.-Conn. | Polymer-modified peptide drugs having enhanced biological and pharmacological activities |
US5162430A (en) * | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
US5306500A (en) * | 1988-11-21 | 1994-04-26 | Collagen Corporation | Method of augmenting tissue with collagen-polymer conjugates |
US5565519A (en) * | 1988-11-21 | 1996-10-15 | Collagen Corporation | Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications |
US5510418A (en) * | 1988-11-21 | 1996-04-23 | Collagen Corporation | Glycosaminoglycan-synthetic polymer conjugates |
EP0401384B1 (en) * | 1988-12-22 | 1996-03-13 | Kirin-Amgen, Inc. | Chemically modified granulocyte colony stimulating factor |
US6166183A (en) * | 1992-11-30 | 2000-12-26 | Kirin-Amgen, Inc. | Chemically-modified G-CSF |
CA2047730A1 (en) * | 1989-02-24 | 1990-08-25 | Carl W. Gilbert | Immobilized cytokines |
US5166322A (en) * | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
US7264944B1 (en) | 1989-04-21 | 2007-09-04 | Amgen Inc. | TNF receptors, TNF binding proteins and DNAs coding for them |
US6221675B1 (en) | 1989-04-21 | 2001-04-24 | Amgen, Inc. | TNF receptors, TNF binding proteins and DNAs coding for them |
DE59010941D1 (de) | 1989-04-21 | 2005-03-24 | Amgen Inc | TNF-Rezeptor, TNF bindende Proteine und dafür kodierende DNAs |
US6143866A (en) * | 1989-07-18 | 2000-11-07 | Amgen, Inc. | Tumor necrosis factor (TNF) inhibitor and method for obtaining the same |
IL95031A (en) | 1989-07-18 | 2007-03-08 | Amgen Inc | A method of producing a recombinant human necrotic factor absorber |
JP2662311B2 (ja) * | 1989-08-07 | 1997-10-08 | デビオファルム ソシエテ アノニム | 生物学的に活性な新規薬剤・ポリマー誘導体およびその製造方法 |
DE3936777A1 (de) * | 1989-11-04 | 1991-05-08 | Basf Ag | Quervernetzte tumor-nekrose-faktoren |
JPH04218000A (ja) * | 1990-02-13 | 1992-08-07 | Kirin Amgen Inc | 修飾ポリペプチド |
US6552170B1 (en) | 1990-04-06 | 2003-04-22 | Amgen Inc. | PEGylation reagents and compounds formed therewith |
US5653974A (en) * | 1990-10-18 | 1997-08-05 | Board Of Regents,The University Of Texas System | Preparation and characterization of liposomal formulations of tumor necrosis factor |
ATE123290T1 (de) * | 1990-10-18 | 1995-06-15 | Univ Texas | Herstellung und charakterisierung der liposomformulierungen des tumornekrosefaktors. |
CA2100329C (en) * | 1991-01-18 | 2009-09-29 | David F. Carmichael | Methods for treating tumor necrosis factor mediated diseases |
WO1993012145A1 (en) * | 1991-12-19 | 1993-06-24 | Baylor College Of Medicine | Pva or peg conjugates of peptides for epitope-specific immunosuppression |
US5446090A (en) * | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
US5629384A (en) * | 1994-05-17 | 1997-05-13 | Consiglio Nazionale Delle Ricerche | Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces |
US20030053982A1 (en) | 1994-09-26 | 2003-03-20 | Kinstler Olaf B. | N-terminally chemically modified protein compositions and methods |
US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
TW555765B (en) | 1996-07-09 | 2003-10-01 | Amgen Inc | Low molecular weight soluble tumor necrosis factor type-I and type-II proteins |
IT1291114B1 (it) | 1997-03-20 | 1998-12-29 | Angeletti P Ist Richerche Bio | Varianti del fattore neurotrofico ciliare (cntf) con migliorata selettivita' al recettore, e metodo per la loro selezione |
US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
DE10144252A1 (de) * | 2001-08-31 | 2003-03-27 | Fraunhofer Ges Forschung | Nanopartikel mit daran immobilisiertem biologisch aktivem TNF |
US7179891B2 (en) | 2002-03-25 | 2007-02-20 | Tadanori Mayumi | Physiologically active complex |
JP4177604B2 (ja) * | 2002-03-25 | 2008-11-05 | 株式会社林原生物化学研究所 | 生理活性複合体 |
TW200526780A (en) | 2004-01-06 | 2005-08-16 | Hayashibara Biochem Lab | TNF antagonists and TNF inhibitors comprising the same as the active ingredient |
US20070065514A1 (en) * | 2005-09-22 | 2007-03-22 | Howell Mark D | Method for enhancing immune responses in mammals |
CN101219219B (zh) * | 2007-01-10 | 2013-02-13 | 北京普罗吉生物科技发展有限公司 | 包含血管抑素或其片段的复合物、其制备方法及应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US4414147A (en) * | 1981-04-17 | 1983-11-08 | Massachusetts Institute Of Technology | Methods of decreasing the hydrophobicity of fibroblast and other interferons |
US4609546A (en) * | 1982-06-24 | 1986-09-02 | Japan Chemical Research Co., Ltd. | Long-acting composition |
DE3572982D1 (en) * | 1984-03-06 | 1989-10-19 | Takeda Chemical Industries Ltd | Chemically modified lymphokine and production thereof |
EP0229108B1 (en) * | 1985-06-26 | 1990-12-27 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
AU580431B2 (en) * | 1985-06-26 | 1989-01-12 | Cetus Corp | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
-
1987
- 1987-03-26 CA CA000533061A patent/CA1283046C/en not_active Expired - Fee Related
- 1987-05-27 DE DE8787304703T patent/DE3780218T2/de not_active Expired - Fee Related
- 1987-05-27 AT AT87304703T patent/ATE77959T1/de not_active IP Right Cessation
- 1987-05-27 NO NO872227A patent/NO872227L/no unknown
- 1987-05-27 EP EP87304703A patent/EP0247860B1/en not_active Expired - Lifetime
- 1987-05-28 AU AU73479/87A patent/AU595321B2/en not_active Ceased
- 1987-05-28 FI FI872393A patent/FI872393A/fi not_active IP Right Cessation
- 1987-05-29 JP JP62131911A patent/JPS62289522A/ja active Pending
- 1987-05-29 DK DK277187A patent/DK277187A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPS62289522A (ja) | 1987-12-16 |
DE3780218T2 (de) | 1992-12-17 |
CA1283046C (en) | 1991-04-16 |
NO872227D0 (no) | 1987-05-27 |
DK277187D0 (da) | 1987-05-29 |
EP0247860B1 (en) | 1992-07-08 |
EP0247860A2 (en) | 1987-12-02 |
EP0247860A3 (en) | 1989-10-11 |
ATE77959T1 (de) | 1992-07-15 |
DK277187A (da) | 1987-12-01 |
AU595321B2 (en) | 1990-03-29 |
FI872393A0 (fi) | 1987-05-28 |
NO872227L (no) | 1987-11-30 |
DE3780218D1 (de) | 1992-08-13 |
AU7347987A (en) | 1987-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI872393A (fi) | Tumoer nekrosfaktorformulation. | |
ES2061589T3 (es) | Sistema de liberacion de principios activos implantable y biologicamente degradable. | |
IE861706L (en) | Solubilization of proteins for pharmaceutical compositions¹using polymer conjugation | |
IT1141954B (it) | Procedimento per ottenere eparine di basso peso molecolare dotate di proprieta' farmacologiche elevate,e prodotto cosi' ottenuto | |
DK0644771T3 (da) | Lægemiddelsystem til levering af erythropoietin | |
DE3673419D1 (de) | Harnroehrendauerkatheter. | |
DE68904101T2 (de) | Polymerzusammensetzungen. | |
NO891982L (no) | Polymer-sammensetning. | |
DE68922460T2 (de) | Thermoplastische Polymerzusammensetzung. | |
DE68916357D1 (de) | Kern-Schale-Polymer, Zusammensetzung und Formteile davon. | |
DE3776119D1 (de) | Sequenziert aufgebaute copolymere auf der basis von cyclischen carbonaten und estern. | |
DE68911717T2 (de) | Thermoplastische Polymerzusammensetzung. | |
DE68922438T2 (de) | Härtbare Polymerzusammensetzung. | |
BE874155A (fr) | Compositions thermoplastiques a base de poly(epsilon-caprolactone) et d'une polydiolefine | |
ZA858787B (en) | Water soluble polymers | |
FR2377381A1 (fr) | Derives de piperidine et leur utilisation comme stabilisants de polymeres | |
DE68914047T2 (de) | Polymer-Zusammensetzungen. | |
JPS56163144A (en) | Polyoxymethylene composition | |
DE68913798D1 (de) | Härtbare Polymerzusammensetzung. | |
FR2616326B1 (fr) | Compositions therapeutiques a base de nouveaux aminoacylates d'acetal du glycerol | |
IL74692A (en) | Pharmaceutical compositions comprising 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-10h-benzo(4,5)-cyclohepta(1,2-b)-thiophen-10-one and a biodegradable polymer | |
ATE53853T1 (de) | Photosensibilisierende zusammensetzungen und diese enthaltende unter lichteinwirkung abbaubare polymerzusammensetzung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed |
Owner name: CETUS CORPORATION |